Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$453M |
| 2 |
UiPath
PATH
|
+$149M |
| 3 |
Roku
ROKU
|
+$135M |
| 4 |
Zoom
ZM
|
+$125M |
| 5 |
Ginkgo Bioworks
DNA
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGFY
Signify Health, Inc.
SGFY
|
+$456M |
| 2 |
Spotify
SPOT
|
+$133M |
| 3 |
Stratasys
SSYS
|
+$118M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$108M |
| 5 |
Coinbase
COIN
|
+$86.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.64% |
| 2 | Technology | 30.32% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Communication Services | 8.55% |
| 5 | Financials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.43T
| $1.08B | 7.54% |
4,080,917
-250,102
| -6% | -$69.8M |
|
|
2
Zoom
ZM
$31.5B
| $801M | 5.59% |
10,891,340
+1,315,322
| +14% | +$125M |
|
|
3
Roku
ROKU
$23.4B
| $672M | 4.69% |
11,917,866
+1,773,302
| +17% | +$135M |
|
|
4
UiPath
PATH
$8.49B
| $581M | 4.05% |
46,084,074
+8,488,829
| +23% | +$149M |
|
|
EXAS
5
DELISTED
Exact Sciences
EXAS
| $571M | 3.98% |
17,561,702
+2,589,937
| +17% | +$107M |
|
6
Intellia Therapeutics
NTLA
$1.8B
| $540M | 3.77% |
9,657,052
+142,472
| +1% | +$8.84M |
|
|
7
CRISPR Therapeutics
CRSP
$5.75B
| $538M | 3.75% |
8,237,122
-1,490,409
| -15% | -$108M |
|
8
Teladoc Health
TDOC
$1.16B
| $529M | 3.69% |
20,858,302
+564,340
| +3% | +$19.8M |
|
|
XYZ
9
Block Inc
XYZ
$49.4B
| $505M | 3.52% |
9,191,790
+56,211
| +0.6% | +$3.98M |
|
|
10
Coinbase
COIN
$49.2B
| $498M | 3.47% |
7,717,135
-1,234,090
| -14% | -$86.2M |
|
11
Twilio
TWLO
$34.6B
| $472M | 3.29% |
6,826,631
+1,254,195
| +23% | +$100M |
|
12
Beam Therapeutics
BEAM
$3.07B
| $405M | 2.82% |
8,490,936
-301,128
| -3% | -$17.2M |
|
|
13
Ginkgo Bioworks
DNA
$498M
| $396M | 2.76% |
3,170,471
+986,520
| +45% | +$118M |
|
|
14
Shopify
SHOP
$192B
| $392M | 2.73% |
14,532,528
+13,319,042
| +1,098% | +$453M |
|
15
DraftKings
DKNG
$13B
| $374M | 2.61% |
24,707,394
-568,419
| -2% | -$9.03M |
|
16
Unity
U
$20.7B
| $359M | 2.5% |
11,263,159
+2,087,448
| +23% | +$85.9M |
|
17
Robinhood
HOOD
$97.2B
| $332M | 2.32% |
32,910,470
-646,319
| -2% | -$6.21M |
|
18
Roblox
RBLX
$27.4B
| $304M | 2.12% |
8,474,696
+1,069,592
| +14% | +$44.2M |
|
19
Fate Therapeutics
FATE
$279M
| $261M | 1.82% |
11,655,833
+182,178
| +2% | +$5.26M |
|
20
PagerDuty
PD
$950M
| $250M | 1.74% |
10,821,427
-61,552
| -0.6% | -$1.59M |
|
21
Twist Bioscience
TWST
$9.13B
| $235M | 1.64% |
6,676,908
+409,187
| +7% | +$17.4M |
|
22
NVIDIA
NVDA
$5.2T
| $168M | 1.17% |
13,826,240
+7,067,380
| +105% | +$112M |
|
23
Pacific Biosciences
PACB
$420M
| $167M | 1.16% |
28,692,494
+646,964
| +2% | +$3.71M |
|
24
Ionis Pharmaceuticals
IONS
$9.93B
| $164M | 1.14% |
3,713,107
-988,190
| -21% | -$41.6M |
|
25
Veracyte
VCYT
$3.4B
| $151M | 1.05% |
9,081,363
+225,118
| +3% | +$5.07M |
|
Similar funds
Cathie Wood's Q3 2022 Portfolio in Review
As of Q3 2022, Cathie Wood held 361 positions worth $14.3B, down 15% from $16.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Cathie Wood's Q3 2022 filing shows 10 new, 102 increased, 126 reduced and 111 closed positions. Its largest new stake was SomaLogic, Inc. Class A Common Stock: 11,017,672 shares worth $32M. The largest sale was Signify Health, Inc., an estimated $456M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cathie Wood's largest Q3 2022 buy was SomaLogic, Inc. Class A Common Stock: 11,017,672 shares worth $32M.
- Cathie Wood added most to Shopify in Q3 2022, an estimated $453M increase.
- Cathie Wood's biggest Q3 2022 reduction was Signify Health, Inc., cutting an estimated $456M.
- Cathie Wood fully exited 1Life Healthcare in Q3 2022, selling an estimated $49.1M.
- Cathie Wood's ten largest holdings make up 44% of its $14.3B portfolio in Q3 2022.
- Cathie Wood opened 10 new positions and closed 111 in Q3 2022.
- Cathie Wood's portfolio value fell 15% quarter-over-quarter to $14.3B.
Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.